The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
As of close of business last night, Evolent Health Inc’s stock clocked out at $10.62, up 1.14% from its previous closing price of $10.5. In other words, the price has increased by $1.14% from its previous closing price. On the day, 3.65 million shares were traded. EVH stock price reached its highest trading level at $10.645 during the session, while it also had its lowest trading level at $10.24.
Ratios:
To gain a deeper understanding of EVH’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.98 and its Current Ratio is at 0.98. In the meantime, Its Debt-to-Equity ratio is 1.14 whereas as Long-Term Debt/Eq ratio is at 0.92.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Needham on January 10, 2025, initiated with a Buy rating and assigned the stock a target price of $15.
On December 03, 2024, BTIG Research reiterated its Buy rating and also upped its target price recommendation from $36 to $29.
Stephens Downgraded its Overweight to Equal-Weight on November 08, 2024, whereas the target price for the stock was revised from $38 to $16.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Mar 06 ’25 when Holder Diane bought 2,735 shares for $9.33 per share. The transaction valued at 25,518 led to the insider holds 70,584 shares of the business.
McCarthy Daniel Joseph bought 11,040 shares of EVH for $99,470 on Mar 06 ’25. The PRESIDENT now owns 389,004 shares after completing the transaction at $9.01 per share. On Mar 07 ’25, another insider, Jelinek Richard M, who serves as the Director of the company, bought 30,000 shares for $9.12 each. As a result, the insider paid 273,750 and bolstered with 15,000 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, EVH now has a Market Capitalization of 1246787968 and an Enterprise Value of 2047234816. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.52 while its Price-to-Book (P/B) ratio in mrq is 1.32. Its current Enterprise Value per Revenue stands at 0.853 whereas that against EBITDA is 24.247.
Stock Price History:
The Beta on a monthly basis for EVH is 0.91, which has changed by -0.48917747 over the last 52 weeks, in comparison to a change of 0.11213791 over the same period for the S&P500. Over the past 52 weeks, EVH has reached a high of $33.63, while it has fallen to a 52-week low of $7.06. The 50-Day Moving Average of the stock is 18.82%, while the 200-Day Moving Average is calculated to be -24.02%.
Shares Statistics:
It appears that EVH traded 2.42M shares on average per day over the past three months and 3660370 shares per day over the past ten days. A total of 115.86M shares are outstanding, with a floating share count of 114.29M. Insiders hold about 2.65% of the company’s shares, while institutions hold 108.95% stake in the company. Shares short for EVH as of 1748563200 were 17455454 with a Short Ratio of 7.20, compared to 1745971200 on 16752521. Therefore, it implies a Short% of Shares Outstanding of 17455454 and a Short% of Float of 15.049999999999999.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
